Obeticholisch zuur CAS 459789 -99-2 behandeling van de cholestasche leverziekte

verzendgebied
wereldwijd/alle landen
cas
459789-99-2
analyse
99%
leveringsmethode
fedex/dhl/speciale lijn
productnaam
obeticholisch zuur
service
goede service
opslag
bewaar het op een koele en droge plaats
testmethode
HPLC
levering
express 5-7 dagen aankomen
uiterlijk
wit poeder
houdbaarheid
2 jaar
Transportpakket
Foil Bag
Specificatie
99%
Handelsmerk
Xi′an Frazer Biotech Co., Ltd.
Oorsprong
China
Productiecapaciteit
200kg Per Month
Referentieprijs
$ 9.00 - 90.00
Neem contact met ons op

Beschrijving

Obeticholic Acid CAS 459789-99-2 Treatment of Cholestatic Liver Disease
Obeticholic Acid CAS 459789-99-2 Treatment of Cholestatic Liver Disease
Obeticholic Acid CAS 459789-99-2 Treatment of Cholestatic Liver Disease

Specification of Analysis

Product name

Obeticholic Acid 

Appearance white Powder
Cas 459789-99-2 
MF C26H44O4
Assay 99%min
Shelf Life 24 months when properly stored

Obeticholic acid is a semi-synthetic bile acid analogue and acts as a farnesoid-X receptor (FXR) agonist. It is used for the treatment of primary biliary cholangitis. It is also under investigation for the treatment of other liver diseases,primary biliary cirrhosis, bile acid diarrhea and related disorders. Study has shown that it also has potential for treating nonalcoholicsteatohepatitis (NASH), and portal hypertension. Obeticholic acid takes effect through acting s the agonist of the farnesoid X receptor (FXR), which is the regulator of bile and cholesterol metabolism in the liver.

Function

Obeticholic acid (OCA) is a synthetically modified bile acid and potent agonist of the farnesoid X nuclear receptor (FXR) that is used to treat liver diseases including primary biliary cholangitis. Obeticholic acid has not been linked to elevations in serum enzyme levels during therapy, but has been linked to an increased rate of severe liver related adverse events such as ascites, jaundice and liver failure.

 

 

 
 
 
 
 
 

 

Farmaceutische Tussenproducten

MAPABLE.CO.ZA, 2023